Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

L Dugas; C Dubray; J P Herry; Niels Vidiendal Olsen; M Court-Payen; J M Hansen; P Robach; A Ter-Minassian; J P Richalet

Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

Translated title of the contribution: Cardiovascular effects of a calcium channel blocker in hypoxia caused by altitude

L Dugas, C Dubray, J P Herry, Niels Vidiendal Olsen, M Court-Payen, J M Hansen, P Robach, A Ter-Minassian, J P Richalet

Eyepath Lab

6 Citations (Scopus)

Abstract

High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.

Translated title of the contribution	Cardiovascular effects of a calcium channel blocker in hypoxia caused by altitude
Original language	French
Journal	Presse Medicale
Volume	24
Issue number	16
Pages (from-to)	763-8
Number of pages	6
ISSN	0755-4982
Publication status	Published - 29 Apr 1995

Cite this

@article{b55ed75f6f624f3b8a7ce81fda309ab4,

title = "Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude",

abstract = "High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.",

keywords = "Adult, Altitude Sickness, Anoxia, Capillary Permeability, Cardiovascular Diseases, Color Perception, Double-Blind Method, Female, Hemodynamics, Humans, Isradipine, Kidney Function Tests, Male, Middle Aged, Placebos",

author = "L Dugas and C Dubray and Herry, {J P} and Olsen, {Niels Vidiendal} and M Court-Payen and Hansen, {J M} and P Robach and A Ter-Minassian and Richalet, {J P}",

year = "1995",

month = apr,

day = "29",

language = "Fransk",

volume = "24",

pages = "763--8",

journal = "Presse Medicale",

issn = "0755-4982",

publisher = "Elsevier Masson",

number = "16",

}

TY - JOUR

T1 - Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

AU - Dugas, L

AU - Dubray, C

AU - Herry, J P

AU - Olsen, Niels Vidiendal

AU - Court-Payen, M

AU - Hansen, J M

AU - Robach, P

AU - Ter-Minassian, A

AU - Richalet, J P

PY - 1995/4/29

Y1 - 1995/4/29

N2 - High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.

AB - High altitude pulmonary oedema can be successfully treated and prevented by calcium channel blockers. Moreover, calcium entering in the cells could explain the congestive phenomena of acute mountain sickness (AMS). These findings led us to study the action of a calcium channel blocker, isradipine, in the prevention of non-complicated AMS.

KW - Adult

KW - Altitude Sickness

KW - Anoxia

KW - Capillary Permeability

KW - Cardiovascular Diseases

KW - Color Perception

KW - Double-Blind Method

KW - Female

KW - Hemodynamics

KW - Humans

KW - Isradipine

KW - Kidney Function Tests

KW - Male

KW - Middle Aged

KW - Placebos

M3 - Tidsskriftartikel

C2 - 7784415

SN - 0755-4982

VL - 24

SP - 763

EP - 768

JO - Presse Medicale

JF - Presse Medicale

IS - 16

ER -

Effets cardiovasculaires d'un bloqueur calcique en hypoxie d'altitude

Abstract

Fingerprint

Cite this